Oxidative Medicine and Cellular Longevity / 2018 / Article / Tab 3

Corrigendum

Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”

Table 3

Short and long-term outcome after aSAH.

Comparison groupsN total
Group A + B
Odds ratio for poor outcome
Group A/B
ZHeterogeneity
Group AGroup BChi2DfI2

Short-term outcome
Hp2-2Hp1-1192 (132 + 60)2.37 (1.12, 5.04)2.260.023.93324%
Hp2-1Hp1-1228 (168 + 60)1.53 (0.74, 3.14)1.160.255.92432%
Hp2-2Hp2-1300 (132 + 168)1.90 (1.11, 3.25)2.340.021.7940%
Hp2-2Hp1-1 & Hp2-1360 (132 + 228)2.07 (1.26, 3.41)2.870.0041.7740%
Hp2-1 & Hp2-2Hp1-1360 (300 + 60)1.96 (0.99, 3.86)1.940.055.11422%
Long-term outcome
Hp2-2Hp1-1216 (155 + 61)1.61 (0.81, 3.16)1.370.174.96260%
Hp2-1Hp1-1266 (205 + 61)1.28 (0.65, 2.51)0.720.473.58244%
Hp2-2Hp2-1360 (155 + 205)1.34 (0.85, 2.10)1.270.200.5520%
Hp2-2Hp1-1 & Hp2-1421 (155 + 266)1.37 (0.89, 2.10)1.440.151.5520%
Hp2-1 & Hp2-2Hp1-1421 (360 + 61)1.41 (0.75, 2.65)1.060.294.26253%

; Z: test for overall effect.